Navigation Links
Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
Date:8/27/2008

etaminophen, warfarin, erythromycin and phenytoin. (Please see full Prescribing Information for other potential drug interactions).

For daily dosing of 800 mg and above, dosing should be accomplished using the 400 mg tablets to reduce exposure to iron.

Common side effects of Gleevec tablets

The majority of adult Ph+ CML patients who received Gleevec in clinical studies experienced adverse reactions at some time, but most were mild to moderate in severity. The most frequently reported adverse reactions (all Grades) were superficial edema (60%-74%), nausea (50%-73%), muscle cramps (28%-62%), vomiting (23%-58%), diarrhea (43%-57%), musculoskeletal pain (38%- 49%) and rash and related terms (36%-47%).*+

* Numbers indicate the range of percentages in 4 studies among adult patients with Ph+ CML in blast crisis, accelerated phase, and chronic phase.

+ For more detailed study information, please see full Prescribing Information.

The adverse reactions and safety profile for Ph+ ALL, MDS/MPD, ASM and HES/CEL were generally similar to the safety profile for Ph+ CML.

The most frequently reported drug-related adverse reactions reported in the Ph+ ALL studies were mild nausea, vomiting, diarrhea, myalgia, muscle cramps and rash, which were easily manageable. Superficial edemas were also a common finding in all studies and were described primarily as periorbital or lower-limb edemas. However, these edemas were rarely severe and may be managed with diuretics, other supportive measures, or, in some patients, by reducing the dose of Gleevec.

Frequently reported adverse reactions (all Grades) in the seven MDS/MPD patients assessed were nausea (57%); diarrhea and muscle cramps (43% each); anemia, fatigue, arthralgia and periorbital edema (29% each).

All ASM patients experienced at least one adverse reaction at some time. The most frequently reported adverse reactions were diarrhea, nausea, ascites, muscle cramps, dyspnea, f
'/>"/>

SOURCE Novartis
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia
2. TorreyPines Therapeutics Receives NASDAQ Deficiency Notice
3. Omaxe Infrastructure & Construction Private Ltd Receives LoI for Construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP With Construction Value of Approx 250 Crores
4. Caliper Life Sciences Receives $1.1 Million Task Order from the EPAs ToxCast(TM) Screening Program
5. Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents
6. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
7. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
8. CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
9. SGX - Lilly Merger Offer Receives Positive Opinions From Proxy Advisory Firms
10. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
11. Medicsight Receives Brazilian State Food and Drug Administration Approval for ColonCAD Software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... for Atomic Force Microscopy (AFM) have been developed and are ... the liquid/air interface. The NeedleProbes’ cylindrical geometry enables researchers ... and viscosity - all in a single force distance curve. ... ... -- New, constant diameter NeedleProbes are enabling unique ...
(Date:12/15/2009)... 15 The International Society for Medical ... society is continuing to accept abstracts for its ... Arlington, VA, April 19-21, 2010. This marks the ... to join the organization to submit an abstract ... is 12 AM EST, January 15, 2010. For ...
(Date:12/15/2009)... MANOR, N.Y., Dec. 15 On January ... International Society for Medical Publication Professionals (ISMPP) will ... in London, UK. More than 100 attendees are ... forum for publication professionals, editors, publishers, medical writers ... of medical publications and the impact of guidelines ...
(Date:12/15/2009)... MONT-SAINT-GUIBERT, Belgium, December 15 , ... Study Designed to Evaluate the Ability of,Cardiopoietic Cells ... Cardio3 BioSciences, a leading Belgian biotechnology company ... diseases,announced today that it has completed, two months ... its pivotal Phase II/III trial of C-Cure, a,unique ...
Breaking Biology Technology:New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 2New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 3The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 2The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 3Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 3
... to ... 66.3% - Company Prepares to Launch Newest Generation of Laser Lipolysis ... Technology, WESTFORD, Mass., ... array of,light-based aesthetic treatment systems, today announced record revenues,and gross margin for the quarter ended March ...
... released a collection of important papers addressing a ... and social implications. The anthology Nanotechnology and ... contentious issues as environmental impact, health dangers, medical ... international governance, and more. , The anthology features ...
... Dacogen Royalty Revenue Increases 114% from Same Prior Year ... SUPG ) today reported financial results for the ... the 2008 first quarter were $8.1 million, compared,with $4.4 ... for the,2008 first quarter consisted of $8.1 million in ...
Other Biology Technology:Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 2Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 3Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 4Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 5Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 6Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 7Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 8Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 9Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 10Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 11Springer publishes anthology with the Nanoethics Group 2SuperGen Reports 2008 First Quarter Financial Results 2SuperGen Reports 2008 First Quarter Financial Results 3SuperGen Reports 2008 First Quarter Financial Results 4SuperGen Reports 2008 First Quarter Financial Results 5SuperGen Reports 2008 First Quarter Financial Results 6SuperGen Reports 2008 First Quarter Financial Results 7SuperGen Reports 2008 First Quarter Financial Results 8SuperGen Reports 2008 First Quarter Financial Results 9
(Date:12/15/2009)... as babies are born, they are susceptible to diseases ... to a month, their immune systems aren,t adequately developed ... they can lead to serious problems if left untreated. ... researchers have pinpointed a group of depleted white blood ... "We,re trying to improve the immune system of newborns ...
(Date:12/15/2009)... VIB and Ghent University in Flanders, Belgium have found ... the major cause of death in intensive care units. ... in mice with septic shock, researchers Anje Cauwels and ... less damage, while their chances of survival increased significantly. ... assumed that nitric oxide is responsible for the potentially ...
(Date:12/15/2009)... In the near future, consumers can look forward ... such as laptops, PDAs and mobile phones. This ... energy harvesting technologies which are critical elements for ... devices and systems. , Analog IC design is ... energy harvesting. To pre-position the nation in advanced ...
Breaking Biology News(10 mins):Researchers work on vaccine to improve immune system in newborns 2Septic shock: Nitric oxide beneficial after all 2NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 2NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 3Bioheart Inc Announces Receipt of 242 8 Million in Proceeds From Pipe Financing 51264 1Bioheart Inc Announces Receipt of 242 8 Million in Proceeds From Pipe Financing 51264 2Bioheart Inc Announces Receipt of 242 8 Million in Proceeds From Pipe Financing 51264 3Blue Cross and Blue Shield of Illinois Awards 241 4 Million to 14 Community Initiatives in Chicago and Downstate 51262 1Blue Cross and Blue Shield of Illinois Awards 241 4 Million to 14 Community Initiatives in Chicago and Downstate 51262 2Oral body inflammatory connection explained 51261 1Oral body inflammatory connection explained 51261 2Oral body inflammatory connection explained 51261 3
... so-called Jekyll and Hyde bacteria, suggesting a novel way ... at the University of York studied the relationship between ... and discovered an unexpected interaction. , Plants are ... thrive on plant food only because of the presence ...
... For Immediate Release - A catalytic antibody discovery made ... of the upcoming acquisition of biotechnology venture CovX by ... that our scientific findings have found such a broad ... M.D., president of Scripps Research. "This development underlines the ...
... and vegetation allowed human ancestors to evolve in Africa. ... to the idea that ground movements formed mountains and ... , Tectonics [movement of Earths crust] was ultimately responsible ... of the universitys Energy and Geoscience Institute write in ...
Other Biology News:Scripps Research discovery leads to broad potential applications in CovX-Pfizer deal 2Scripps Research discovery leads to broad potential applications in CovX-Pfizer deal 3Scripps Research discovery leads to broad potential applications in CovX-Pfizer deal 4Scripps Research discovery leads to broad potential applications in CovX-Pfizer deal 5Evolution tied to Earth movement 2Evolution tied to Earth movement 3Evolution tied to Earth movement 4
Rabbit polyclonal antibody to NCOA2 [Agarose Immobilized]...
Monocarboxylate (lactate) transporter 2...
Mouse Anti-Human Kallikrein 2 (Hk2)...
... Asb-2 (Ankyrin repeat and SOCS box-containing protein) ... peptides containing amino acids 75-93 and 348-368 ... (Imgenex Catalog No. 40149) can be used ... react with mouse and rat Asb-2, based ...
Biology Products: